EMA About To Name New Executive Director
This article was originally published in Scrip
The European Medicines Agency says it expects to name its new executive director on Oct. 1 at an extraordinary meeting of its management board. The successful applicant will be selected from a shortlist of candidates drawn up by the European Commission.
You may also be interested in...
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.
The EU’s new health commissioner, Stella Kyriakides, has outlined the commission’s plans for dealing with medicines access issues in the EU member states. They include completing the review of the EU pediatric and orphan legislation and developing a new strategic plan to tackle shortages and affordability problems next year.
AstraZeneca’s Lynparza can now be used on the Scottish National Health Service for newly diagnosed advanced ovarian cancer.